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Abstract—Parkinson’s Disease(PD) is one of the major nervous
system disorders that affect people over 60. PD can cause cog-
nitive impairments. In this work, we explore various approaches
to identify Parkinson’s using Magnetic Resonance (MR) T1
images of the brain. We experiment with ensemble architectures
combining some winning Convolutional Neural Network models
of ImageNet Large Scale Visual Recognition Challenge (ILSVRC)
and propose two architectures. We find that detection accuracy
increases drastically when we focus on the Gray Matter (GM)
and White Matter (WM) regions from the MR images instead
of using whole MR images. We achieved an average accuracy
of 94.7% using smoothed GM and WM extracts and one of our
proposed architectures. We also perform occlusion analysis and
determine which brain areas are relevant in the architecture
decision making process.
Index Terms—Parkinson’s Disease Detection, Ensemble Learn-
ing, Deep Learning, Magnetic Resonance Imaging
I. INTRODUCTION
Parkinson’s Disease(PD) is one of the most common neu-
rodegenerative movement disorders with around 6.2 Million
affected globally [1]. PD is mainly caused by loss of nerve
cells (neurons) in Substantia Nigra, which is in the Basal
Ganglia region of the brain. Neurons in this part of the brain
are responsible for producing an organic chemical known as
dopamine, which acts as a neurotransmitter in the brain by
helping the neurons communicate. If the amount of dopamine
produced in the brain is not sufficient, communication between
neurons for coordinating body movement is hampered; causing
PD, which has multiple neurological and motor symptoms like
tremors, balance issues, Bradykinesia, impaired gait, stooped
posture, speech problems etc. PD has been clinically defined
and studied for decades, but it’s exact mechanisms are still
unclear [2]. PD is usually diagnosed with the manifestation
of motor symptoms, which might not appear until a patient
has lost 50-70% of their neurons [3]. Although a guaranteed
cure for PD has not been found yet, early detection might
play a crucial role in slowing or stopping the progression of
the disease. Some new forms of treatment like Exenatide [6]
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show promising results in case of early detection. Analyzing
the structural changes in the brain using Medical Imaging
techniques have been proven to be helpful for detecting
neurodegenerative diseases with cognitive impairments [4] [5].
In particular, Magnetic Resonance (MR) images provide better
performance in brain structure analysis because of having
high contrast and resolution within soft tissue. In this work,
we propose two ensemble architectures to identify PD from
MR images of the brain, one of which achieves comparable
accuracy to existing state-of-the-art models. We also identify
which region of the brain the network is focusing on using
occlusion analysis.
II. RELATED WORKS
Over the years, various Machine Learning (ML) [2], [7]–
[9] and Deep Learning (DL) [10], [12] based approaches have
been introduced for detecting Parkinson’s Disease. Pazhanira-
jan et al. [8] used a Radial Basis Function Neural Network
(RBFNN) for PD classification. Focke et al. [7] used a SVM
Classifier with Gray Matter (GM) and White Matter (WM)
extracted from MR images. They reported 39.53% and 41.86%
classification accuracy for GM and WM respectively. Babu
et al. [11] proposed a Computer Aided Diagnosis (CAD)
system. They achieved a 87.21% accuracy in classifying
PD using GM and identified Superior Temporal Gyrus as a
potential biomarker. Choi et al. [10] used Convolutional Neural
Network[CNN] and SPECT Imaging to achieve an accuracy
of 96%. But SPECT Imaging requires injecting a radioactive
tracer into the patient so it is invasive and not very popular.
Over one year period in the NHS operation in England, around
100 times more MRI scans were performed compared to
SPECT. Thus the approach seems to be impractical for normal
medical use despite its reported high accuracy. Moreover the
dataset suffers from class imbalance as about 69% of their
data is from PD patients. Class imbalance leads to models
over classifying the majority class [14]. Long et al. [15] used a
ML based approach to detect PD from resting-state functional
MRI (rsf-MRI). rsf-MRI detects subtle changes in blood flow
whereas Structural MRI (sMRI) only captures the anatomical
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details and ignores all activity. Although they achieve 87%
accuracy, the dataset used by them was very small. Rana
et al. [17] used t-test feature selection on WM, GM and
Cerebrospinal Fluid (CSF) and used a SVM for classification
achieving 86.67% accuracy for GM and WM and 83.33%
accuracy for CSF. In their other work [18] they considered
the relation between tissues instead of considering the tissues
separately and achieved an accuracy of 89.67%. Braaks neu-
roanatomical model of Parkinsons Disease [16] identifies the
Substantia Nigra (SN) region as having significant correlation
with PD and it is often used a Region Of Interest (ROI) in PD
identification.
None of the methods we looked into were using ensemble
architectures for PD detection and the detection accuracy
using sMRI was lacking. We believed creating ensemble ar-
chitectures combining different characteristics of deep learning
models might give us better results. We describe our approach
in the next section.
III. PROPOSED METHOD
A. Data
For our experiments, we used Parkinson Progression Mark-
ers Initiative (PPMI) dataset [19]. It consists of T1-weighted
sMRI scans for 568 PD and Healthy Control(HC) subjects
from which we choose 445 subjects and discard the rest due
to some structural anomalies during preprocessing steps. The
resulting data has a class imbalance with 299 PD and 146 HC
subjects. To address this issue, we collect 153 HC T1-weighted
sMRI scans from the publicly available IXI dataset [20]. Our
final dataset has is class balanced with 598 subjects. The
demographic for the dataset is presented in Table I.
TABLE I
DEMOGRAPHIC DATA
PD HC Average
Age(Years) 62.0± 9.54 49.2± 16.9 55.6± 15.1
Sex (Male / Female) 189 / 110 172 / 127 361 / 237
B. Preprocessing
There are morphological and dimensional differences be-
tween data since the scans come from different machines. To
make the data comparable we had to standardize it to a com-
mon format, all scans were resized to the same dimensions. For
preprocessing, Statistical Parameter Mapping (SPM12) [21],
[22] and Computational AnatomTtoolbox (CAT12) [23] were
used.
Fig. 1 shows the structure of our preprocessing pipeline.
MRI intensity varies from subject to subject. To minimize dis-
crepancies we normalize the values to [0,1]. Then all images
were aligned to a standard space named Montreal Neurological
Institute (MNI). Then a bias field correction (FAST) [25]
is performed to remove general intensity non-uniformities.
FNIRT / BET [26] was used to extract brain from the scans
removing the skull, fat and background regions which do not
contain useful information. The data was registered to MNI152
Fig. 1. Preprocessing Pipeline
format (FLIRT) [27], [28]. After that artifact removal was
performed, i.e. any voxel intensity values higher than 1 is
corrected to be in the range [0,1]. Then a deformation method
was applied to extract Gray Matter (GM) and White Matter
(WM) from the scan and a 8mm Isotropic Gaussian Kernel
was used to smooth and increase the signal-to-noise ratio and
remove unnecessary portions of the scan. Finally we have three
separate datasets: whole brain scans, GM and WM extracted
from the brain and Smoothed GM and WM. An example of
the extracted brain and the resultant WM and GM extracted
from the brain is given in Fig. 2.
C. Model
We created two separate ensemble architectures combining
existing models implemented in Pytorch [31]. We selected 6
models to construct our ensemble architecture:
• ResNet 101
• SqueezeNet 1.1
• DenseNet 201
• VGG 19
• MobileNet V2
• ShuffleNet V2
These models are available from Torchvision [32] in two
versions: without any kind of training (untrained) and trained
on the ImageNet [29] dataset. We used both untrained and
pre-trained models to construct our ensemble networks and
compared the performances of the resultant networks. The
models are designed for the ImageNet [29] dataset, so we
needed to modify them in order to accommodate our MRI data.
The input layers of all models were changed to accommodate
the shape of our input and the output layers were changed to
predict between 2 classes (PD and HC) instead of the 1000
imagenet classes.
1) Ensemble model for Whole Brain Scan: Model 1: In
this architecture, we pass our whole brain scan of dimensions
91 × 109 × 91 through six models in parallel and the con-
catenated output is passed through a Rectified Linear Unit
(a) Whole Brain
(b) Extracted White Matter
(c) Extracted Gray Matter
Fig. 2. Sample MRI scans for a Healthy Control Patient and the extracted
GM and WM
(ReLU) activation function and then to a Linear layer with 2
output classes. Fig. 3 shows a visual representation of this
architecture.
2) Ensemble model for Extracted GM and WM Scans:
Model 2: This architecture is trained on the extracted GM and
WM scans of dimension 121× 145× 121. It is comprised of
four models. The GM scans are passed through ShuffleNet and
SqueezeNet and the WM scans are passed through DenseNet
and MobileNet. The output of all models are concatenated and
passed through a ReLU activation layer and a linear layer with
2 output classes to get final predictions. Fig. 4 shows a visual
representation of this architecture.
IV. EXPERIMENTAL RESULTS
Two versions were constructed for each of our ensemble
architectures; one with all untrained constituent models and
another with all pretrained constituent models. The dataset was
split randomly, and 80% was selected for training and 20%
for testing. Each model was trained for 25 epochs with an
Adam Optimizer and Cross Entropy Loss function. At each
epoch, the training set was further split randomly, and 20%
was selected for validation. We repeated the procedures listed
above 5 times to obtain an average for 2 different learning
rates .001 and .0001. The results are presented in Table II.
For whole brain scans, the best results we achieved was an
average accuracy of 0.7617 ± 0.0041 with a Learning Rate
of .001. As shown in Table II, using pre trained models as
constituents of our architecture does not help our predictions
in this case.
We can see a drastic increase in performance when we use
the extracted GM and WM scans with pre-trained constituent
models for Model 2. The best average accuracy for non-
smoothed regions is 0.9366± 0.0170.
For the same model architecture, we get even better average
accuracy of 0.9470±0.0083 by using Smoothed GM and WM
extractions, which significantly outperforms all the existing
work we mentioned on sMRI for PD identification. Since this
is the best accuracy we have achieved, we used this method to
perform occlusion analysis and identify the Region Of Interest
(ROI) according to the method proposed by Rieke et al. [30].
1) Occlusion Analysis: To understand which regions of the
brain are important in the decision making process we perform
a slightly modified version of occlusion analysis proposed in
[30] to fit our data. In this analysis, usually a part of the scan
is occluded with gray or white patch and the output from the
network is recalculated. The occluded region is considered to
be important if the probability of the target class decreases
compared to the original image. The heatmap of relevance is
calculated by sliding the patch across the image and plotting
the difference in the probability. In our case we repeated the
procedure twice, once for each of the GM and WM images.
The resultant heatmaps are presented in Fig. 5, where the
important areas are marked in red.
To better understand the above heatmaps we also calculated
the relevance per brain area using methods provided by [30]
which is presented in Fig. 6 and Fig. 7. We can see for Gray
Matter the most focused on area is Superior Frontal Gyrus and
for White Matter it is Postcentral Gyrus.
V. CONCLUSION AND FUTURE WORKS
In this paper we proposed two novel deep learning archi-
tectures for Parkinson’s Disease Detection using Ensemble
Learning, which outperforms related works. We achieved
higher accuracy using smoothed GM and WM with our second
ensemble architecture. We also applied occlusion analysis to
identify the region of significance for model decision. Our next
step will be to analyse the decision making process of our
model using the Substantia Nigra as the target of significance
to assess if it produces better results than using GM and WM
regions
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TABLE II
RESULTS
Model
Use
Smoothed
Scan
Pre Trained Learning Rate
Classification
Accuracy
(On a scale of 0-1)
Model 1
Whole Brain Scans N/A
False
.001 0.7617± 0.0041
.0001 0.7459± 0.0042
True
.001 0.6800± 0.0113
.0001 0.6613± 0.0311
Model 2
Extracted GM and WM
Scans
False
False
.001 0.5487± 0.0002
.0001 0.6847± 0.0093
True
.001 0.9231± 0.0258
.0001 0.9366± 0.0170
True
False
.001 0.5410± 0.0106
.0001 0.7276± 0.0476
True
.001 0.9291± 0.0170
.0001 0.9470± 0.0083
Focke et al. [7] [GM] N/A N/A N/A 0.3953
Focke et al. [7] [WM] N/A N/A N/A 0.4186
Babu et al. [11] [GM] N/A N/A N/A 0.8721
Rana et al. [17] [GM & WM] N/A N/A N/A 0.8667
Rana et al. [18] N/A N/A N/A 0.8967
(a) Heatmap for White Matter
(b) Heatmap for Gray Matter
Fig. 5. Relevance Heatmaps for Occlusion of GM and WM images
Fig. 6. Relevance per brain area for White Matter
Fig. 7. Relevance per brain area for Gray Matter
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